Tissue kallikrein for the treatment of schizophrenia and...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/48 (2006.01) A61P 25/00 (2006.01) A61P 25/28 (2006.01)

Patent

CA 2759481

The invention includes methods of treating psychiatric disorders including schizophrenia, associated conditions of the schizophrenic spectrum and bipolar disorder, comprising administering tissue kallikrein (KLK1), variants or active fragments thereof. The invention also includes compositions comprising KLK1, variants, or active fragments thereof.

L'invention comprend des procédés de traitement de troubles psychiatriques comprenant la schizophrénie, des états associés du spectre schizophrénique et du trouble bipolaire, comportant l'administration de kallicréine tissulaire (KLK1), de variants ou de fragments actifs de celle-ci. L'invention comprend également des compositions comportant KLK1, des variants ou des fragments actifs de celle-ci.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Tissue kallikrein for the treatment of schizophrenia and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tissue kallikrein for the treatment of schizophrenia and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tissue kallikrein for the treatment of schizophrenia and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1416674

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.